{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:41:08Z","timestamp":1790523668524,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.intimp.2009.12.016","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T06:12:11Z","timestamp":1263535931000},"page":"412-421","source":"Crossref","is-referenced-by-count":32,"title":["CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine\/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model"],"prefix":"10.1016","volume":"10","author":[{"given":"Daniel H.","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Bendele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Carambula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Duzant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Talor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2009.12.016_bib1","series-title":"Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis: a primer for clinicians","author":"Dinarello","year":"2002"},{"key":"10.1016\/j.intimp.2009.12.016_bib2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.22567","article-title":"Differential recognition of heat-shock protein DNAJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis","volume":"56","author":"Massa","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2009.12.016_bib3","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.4049\/jimmunol.156.8.2761","article-title":"Characterization of the antigenic structure of human type II collagen","volume":"156","author":"Krco","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.149.4.1439","article-title":"Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis","volume":"149","author":"Myers","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib5","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.4049\/jimmunol.157.11.5178","article-title":"Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains","volume":"157","author":"Brand","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/intimm\/dxh075","article-title":"Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis","volume":"16","author":"Honda","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib7","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.4049\/jimmunol.173.11.7037","article-title":"Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice","volume":"173","author":"Svendsen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib8","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.158.7.3545","article-title":"Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition","volume":"158","author":"Zanelli","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib9","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.4049\/jimmunol.163.3.1661","article-title":"Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice","volume":"163","author":"Krco","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib10","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/1529-0131(199910)42:10<2085::AID-ANR8>3.0.CO;2-Z","article-title":"Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255\u2013274) in patients with rheumatoid arthritis","volume":"42","author":"Kim","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2009.12.016_bib11","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.4049\/jimmunol.160.7.3135","article-title":"Characterization of signal transduction through the TCR-zeta chain following T cell stimulation with analogue peptides of type II collagen 260\u2013267","volume":"160","author":"Tang","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib12","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.4049\/jimmunol.160.6.2573","article-title":"Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen","volume":"160","author":"Rosloniec","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib13","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.161.7.3589","article-title":"Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis","volume":"161","author":"Myers","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pathophys.2005.07.011","article-title":"Animal models of rheumatoid arthritis and their relevance to human disease","volume":"12","author":"Kannan","year":"2005","journal-title":"Pathophysiology"},{"key":"10.1016\/j.intimp.2009.12.016_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/ard.2007.076430","article-title":"Utility of animal models for identification of potential therapeutics for rheumatoid arthritis","volume":"67","author":"Hegen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2009.12.016_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-59745-402-5_14","article-title":"Collagen-induced arthritis in mice","volume":"136","author":"Williams","year":"2007","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.intimp.2009.12.016_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1504s19","article-title":"Adjuvant arthritis in the rat","author":"van Eden","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.8378772","article-title":"Effects of oral administration of type II collagen on rheumatoid arthritis","volume":"261","author":"Trentham","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.intimp.2009.12.016_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.intimp.2009.12.016_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0049-0172(99)80028-6","article-title":"Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis","volume":"29","author":"Franklin","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.intimp.2009.12.016_bib21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.intimp.2009.12.016_bib22","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2009.12.016_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","article-title":"The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation","volume":"18","author":"Kikly","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1196\/annals.1443.021","article-title":"Regulation and function of proinflammatory TH17 cells","volume":"1143","author":"Martinez","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.intimp.2009.12.016_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1164872","article-title":"Immunology. Regulating suppression","volume":"322","author":"Shevach","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2009.12.016_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1398-9995.2006.01005.x","article-title":"Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders?","volume":"61","author":"Romagnani","year":"2006","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.intimp.2009.12.016_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2009.02.030","article-title":"Mechanisms and treatment of allergic disease in the big picture of regulatory T cells","volume":"123","author":"Akdis","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib28","unstructured":"Stratton KR, Durch JD, and Lawrence RS. 2000. Book, Vaccines for the 21st century: A Tool for Decision Making. National Academy Press, ed."},{"key":"10.1016\/j.intimp.2009.12.016_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.intimp.2008.01.004","article-title":"L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart","volume":"8","author":"Cihakova","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2009.12.016_bib30","unstructured":"Rosenthal, K. S., H. Mao, W. I. Horne, C. Wright, and D. Zimmerman. 1998. Immunization with a L.E.A.P.S. heteroconjugate vaccine containing a CTL epitope and a peptide from beta-2-microgl."},{"key":"10.1016\/j.intimp.2009.12.016_bib31","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/S0264-410X(03)00429-8","article-title":"A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection","volume":"21","author":"Goel","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2009.12.016_bib32","article-title":"Ligand epitope antigen presentation system vaccines against herpes simplex virus","volume":"966","author":"Goel","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.intimp.2009.12.016_bib33","first-page":"91","article-title":"A new approach to T cell activation: natural and synthetic conjugates capable of activating T cells","volume":"5","author":"Zimmerman","year":"1996","journal-title":"Vac Res"},{"key":"10.1016\/j.intimp.2009.12.016_bib34","first-page":"103","article-title":"Immunization with peptide heteroconjugates primes a TH1 associated antibody (IgG2a) response which recognizes the native epitope on the 38kDa protein of Mycobacterium tuberculosis","volume":"5","author":"Zimmerman","year":"1996","journal-title":"Vac Res"},{"key":"10.1016\/j.intimp.2009.12.016_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jmv.1890150302","article-title":"Identification and typing of herpes simplex virus types 1 and 2 by monoclonal antibodies, sensitivity to the drug (E)-5-(-2-bromovinyl)-2\u2032-deoxyuridine an restriction endonuclease analysis of viral DNA","volume":"15","author":"Zimmerman","year":"1985","journal-title":"Med Virol"},{"key":"10.1016\/j.intimp.2009.12.016_bib36","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.48.7.2455-2463.2004","article-title":"A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner","volume":"48","author":"Charoenvit","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.intimp.2009.12.016_bib37","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.vaccine.2003.11.062","article-title":"CEL-1000\u2014a peptide with adjuvant activity for Th1 immune responses","volume":"10","author":"Charoenvit","year":"2004","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.intimp.2009.12.016_bib38","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/S0264-410X(01)00247-X","article-title":"Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1SF p17) and peptide segments of human \u03b2-2-microglobulin or MHC II \u03b2 chain","volume":"19","author":"Zimmerman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2009.12.016_bib39","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/S0264-410X(02)00096-8","article-title":"FLT3 ligand and an IL-1-\u03b2 bioactive heteroconjugate as adjuvants for a type 1 cell mediated immune response to HIV gag p17 peptide","volume":"20","author":"Pisarev","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2009.12.016_bib40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2741\/1572","article-title":"The L.E.A.P.S. approach to vaccine development","volume":"10","author":"Zimmerman","year":"2005","journal-title":"Front Biosci"},{"issue":"3","key":"10.1016\/j.intimp.2009.12.016_bib41","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","article-title":"Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection","volume":"179","author":"Zalevsky","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib42","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1016\/S0021-9258(18)32389-5","article-title":"Arginine 45 is a major part of the antigenic determinant of human \u00e22-microglobulin recognized by mouse monoclonal antibody BBM1","volume":"258","author":"Parham","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2009.12.016_bib43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/356799a0","article-title":"Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules","volume":"356","author":"Cammarota","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2009.12.016_bib44","doi-asserted-by":"crossref","unstructured":"Konig R Huang LY Germain RN MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binging site for CD8 Nature 356:796\u20138.","DOI":"10.1038\/356796a0"},{"key":"10.1016\/j.intimp.2009.12.016_bib45","doi-asserted-by":"crossref","unstructured":"Taylor, P, G Koski, P. Cohen, DH Zimmerman KS Rosenthal (2009) J-L.E.A.P.S.\u2122 vaccines initiate murine Th1 responses by activating dendritic cells. (Submitted for publication).","DOI":"10.1016\/j.vaccine.2010.06.043"},{"key":"10.1016\/j.intimp.2009.12.016_bib46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1196\/annals.1443.021","article-title":"Regulation and function of proinflammatory Th17 cells","volume":"1143","author":"Martinez","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2009.12.016_bib47","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2009.12.016_bib48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1681\/ASN.2008080891","article-title":"IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen","volume":"20","author":"Ooi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2009.12.016_bib49","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells curing chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2009.12.016_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2567.2008.02875.x","article-title":"Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo","volume":"126","author":"Jaen","year":"2008","journal-title":"Immunology"},{"issue":"72","key":"10.1016\/j.intimp.2009.12.016_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2144\/Oct0208","article-title":"Toll-like receptor signaling and regulation of cytokine gene expression in the immune system","volume":"70","author":"Ozato","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.intimp.2009.12.016_bib52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpeds.2008.04.032","article-title":"Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization","volume":"153","author":"Siegrist","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.intimp.2009.12.016_bib53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type B tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria\u2013tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.intimp.2009.12.016_bib54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00006454-199804000-00006","volume":"17","author":"Lagos","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.intimp.2009.12.016_bib55","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/IAI.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2009.12.016_bib56","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0264-410X(98)00422-8","article-title":"New acellular pertussis-containing paediatric combined vaccines","volume":"17","author":"Pines","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2009.12.016_bib57","doi-asserted-by":"crossref","unstructured":"Boot HJ, Schipper CM. Simultaneous vaccination with prevenar and multicomponent vaccines for children: 2009 interference or no interference? Hum Vaccin. 205:15\u201317.","DOI":"10.4161\/hv.5.1.6520"},{"key":"10.1016\/j.intimp.2009.12.016_bib58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O'Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.intimp.2009.12.016_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1096\/fasebj.5.2.1825981","article-title":"Functional diversity of T lymphocytes due to secretion of different cytokine patterns","volume":"5","author":"Street","year":"1991","journal-title":"FASEB J"},{"key":"10.1016\/j.intimp.2009.12.016_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2008.03.011","article-title":"Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine","volume":"153","author":"Halasa","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.intimp.2009.12.016_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00063030-199809060-00002","article-title":"Clinically relevant vaccine\u2013vaccine interactions: a guide for practitioners","volume":"9","author":"Gizurarson","year":"1998","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2009.12.016_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jpeds.2007.09.034","article-title":"Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants","volume":"152","author":"Knuf","year":"2008","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.intimp.2009.12.016_bib63","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14656566.5.3.581","article-title":"The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview","volume":"5","author":"Toussirot","year":"2004","journal-title":"Expert Opin Pharmacother"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691000010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691000010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T15:52:37Z","timestamp":1685375557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691000010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S156757691000010X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2009.12.016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}